December 2nd 2024
If granted, guselkumab will be approved to treat children ages 6 and younger with severe plaque psoriasis and children ages 5 and younger with juvenile psoriatic arthritis.
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
HSV, HPV Called 'Silent Epidemics'
August 1st 2003San Francisco - Although bacterial sexually transmitted diseases are decreasing in prevalence in the United States, viral STDs are on the rise, according to Ted Rosen, M.D. Of particular concern, he said, are the increasing numbers of people infected with herpes simplex virus (HSV) and human papilloma virus (HPV).
Should I Add an Online Pharmacy to Increase My Practice Revenues?
July 1st 2003Dr. Dave is always looking for ways to increase his practice revenues. In his practice, he has a good mix of general and surgical dermatology patients, has learned to ethically promote his talents, and has launched a successful Web site. He ponders what else he can do to increase revenues.
Giving Bureaucracy the Ol' College Try
July 1st 2003Having recently returned to my "roots" to assume the position of professor and chief of dermatology at my alma mater, the University of Arizona, I'm struck by the fact that, although many changes have occurred during the 30 years I've been away pursuing other academic positions and activities, much remains the same. Predictably, the campus has grown and
Bucking the One-Time Trendsetter
June 1st 2003San Francisco - According to an analysis of data from more than 700 patients, a new nonsteroid treatment for atopic dermatitis is a safe, effective, and cost-effective alternative to conventional therapy for the chronic, relapsing inflammatory skin disease that primarily affects infants and children.
TIM's: Trying to Draw Comparisons
June 1st 2003San Francisco -- Results of a study evaluating topical tacrolimus ointment 0.03 percent (Protopic) indicate it is a safe and effective treatment for patients of all ages with mild to moderate atopic dermatitis (AD), John Y M Koo, M.D., said at the annual meeting of the American Academy of Dermatology.